| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 9 | |
| #2 | Japan | 9 | |
| #3 | Canada | 3 | |
| #4 | United States | 3 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Sugars | |
| #5 | Measuring electric variables |
| # | Name | Total Patents |
|---|---|---|
| #1 | Matsuo Masafumi | 24 |
| #2 | Takeshima Yasuhiro | 21 |
| #3 | Koizumi Makoto | 19 |
| #4 | Yokoyama Mitsuhiro | 1 |
| #5 | Emoto Kensho | 1 |
| #6 | Sunu Budeii Raharujo | 1 |
| #7 | Saiki Kayoko | 1 |
| #8 | Ikeda Koji | 1 |
| #9 | Yuda Nuruhantari | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP2374885A2 | ENA nucleic acid drugs modifying splicing in mRNA precursor | |
| JP2002010790A | Therapeutic agent for duchenne muscular dystrophy | |
| JP2001275687A | Membrane-bound metalloprotease and soluble secretor thereof | |
| JP2000325085A | Pharmaceutical composition for treatment of duchenne muscular dystrophy |